Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk

被引:34
|
作者
Kormann, M. S. D. [1 ]
Ferstl, R. [2 ]
Depner, M. [1 ]
Klopp, N. [3 ]
Spiller, S. [2 ]
Illig, T. [3 ]
Vogelberg, C. [4 ]
von Mutius, E. [1 ]
Kirschning, C. J. [2 ]
Kabesch, M. [1 ]
机构
[1] Univ Munich, Univ Childrens Hosp, D-80337 Munich, Germany
[2] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany
[3] Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany
[4] Univ Childrens Hosp, Dresden, Germany
关键词
atopy; IgE; polymorphism; toll-like receptor 2; TOLL-LIKE RECEPTOR-2; LEPROMATOUS LEPROSY; CHILDHOOD ASTHMA; POLYMORPHISM; CHILDREN; ASSOCIATION; PREVALENCE; GERMANY; CELLS; EAST;
D O I
10.1111/j.1398-9995.2008.01891.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Common genetic variations in toll-like receptor 2 (TLR2), an innate pathogen recognition receptor, may influence the development of atopic diseases. So far, very little is known about the role of rare TLR2 mutations in these diseases. We investigated the functional properties of six rare amino acid changes in TLR2 (and one amino acid change in a TLR2 pseudogene) and studied their effect on atopic sensitization and disease. We identified rare TLR2 mutations leading to amino acid changes from databases. Functional effects of TLR2 variants were analyzed by NF-kappa B-dependent luciferase reporter assay and interleukin-8 enzyme linked immunosorbent assay in vitro. The frequency of these mutations was determined in a random sample of the general population (n = 368). Association with atopic diseases were studied in a cross sectional German study population (n = 3099). Three out of six mutations in the TLR2 gene altered receptor activity in vitro. Out of these, only the minor allele of R753Q occurred reasonably frequent in the German population (minor allele frequency 3%). The risk to develop atopy increased by 50% in carriers of the 753Q allele (P = 0.021) and total (P = 0.040) as well as allergen specific serum IgE levels (P = 0.011) were significantly elevated. The rare but functionally relevant mutation R753Q in TLR2 may significantly affect common conditions such as atopic sensitization in the general population.
引用
收藏
页码:636 / 642
页数:7
相关论文
共 50 条
  • [31] TLR2 AND TLR4 POLYMORPHISMS IN KAWASAKI DISEASE
    Greber-Platzer, S.
    Kitzmueller, E.
    Sadhegi, K.
    Dangl, A.
    Herkner, K.
    Foerster-Waldl, E.
    PEDIATRIC RESEARCH, 2010, 68 : 440 - 441
  • [32] Expression of TLR2 and TLR4 in colorectal carcinoma
    Guo, Y. W.
    Li, Y. W.
    Wen, Z. F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A64 - A65
  • [33] TLR3 activation stimulates TLR2 expression and innate immune responses to TLR2 ligands in airway epithelial cells
    Melkamu, Tamene
    O'Grady, Scott M.
    FASEB JOURNAL, 2008, 22
  • [35] Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells
    Chen, Shuang
    Wong, Michelle H.
    Schulte, Danica J.
    Arditi, Moshe
    Michelsen, Kathrin S.
    JOURNAL OF ENDOTOXIN RESEARCH, 2007, 13 (05): : 281 - 296
  • [36] TLR2 and TLR4 in Ischemia Reperfusion Injury
    Arslan, F.
    Keogh, B.
    McGuirk, P.
    Parker, A. E.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [37] The Staphylococcus aureus Lipoprotein SitC Colocalizes with Toll-Like Receptor 2 (TLR2) in Murine Keratinocytes and Elicits Intracellular TLR2 Accumulation
    Mueller, P.
    Mueller-Anstett, M.
    Wagener, J.
    Gao, Q.
    Kaesler, S.
    Schaller, M.
    Biedermann, T.
    Goetz, F.
    INFECTION AND IMMUNITY, 2010, 78 (10) : 4243 - 4250
  • [38] Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain
    Mistry, Pragnesh
    Laird, Michelle H. W.
    Schwarz, Ryan S.
    Greene, Shannon
    Dyson, Tristan
    Snyder, Greg A.
    Xiao, Tsan Sam
    Chauhan, Jay
    Fletcher, Steven
    Toshchakov, Vladimir Y.
    MacKerell, Alexander D., Jr.
    Vogel, Stefanie N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (17) : 5455 - 5460
  • [39] TLR2 and TLR3 expression as a biomarker for the risk of doxorubicininduced heart failure
    Shao Liang
    Cai Xinyong
    Zhu Hongmin
    Wang Jing
    Hong Lang
    Zhang Ping
    TOXICOLOGY LETTERS, 2018, 295 : 205 - 211
  • [40] TLR2 is expressed on activated T cells as a costimulatory receptor
    Komai-Koma, M
    Jones, L
    Ogg, GS
    Xu, DM
    Liew, FY
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 3029 - 3034